Group 1 - Teladoc Health Inc. is considered one of the best single-digit stocks to buy according to analysts, with recent price target adjustments reflecting market conditions [1] - Bank of America analyst Allen Lutz lowered the price target for Teladoc to $7 from $7.50, maintaining a Neutral rating, citing trends indicating Q4 2025 revenue may align with consensus but fall slightly below Teladoc's guidance [1] - Goldman Sachs also lowered its price target for Teladoc from $9 to $8 while keeping a Buy rating, noting a sharp decline in MedTech and Healthcare IT stocks that is believed to be disconnected from company fundamentals [2] Group 2 - Citi analyst Daniel Grosslight reduced the price target for Teladoc from $10 to $9, maintaining a Neutral rating, and expressed cautious optimism for a potential recovery in 2026 despite a challenging 2025 for the health tech sector [3] - The health tech and distribution sector faced significant challenges in 2025, with nearly a third of the group experiencing declines of more than 25% [3] - Teladoc operates globally, providing virtual healthcare services through its Integrated Care and BetterHelp segments [4]
BofA Lowers Teladoc (TDOC) PT on Peer Multiple Compression, Soft Sensor Tower Trends